chrX-38286378-CCTTCCTCCCCTTCTT-C
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BP3
This summary comes from the ClinGen Evidence Repository: NM_001034853.2(RPGR):c.2606_2620del (p.Glu869_Glu873del) is a short in-frame deletion of 15 nucleotides that encode amino acids 869–873 within a low-complexity region (PMID:27162334) that extends approximately from amino acids 787–1043 in RPGR (BP3). This variant is present in gnomAD v4.1.0 at a frequency of 0.007397 among hemizygous individuals, with 1,400 variant alleles / 189,256 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP3. (date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10385260/MONDO:0100437/106
Frequency
Consequence
NM_001034853.2 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
 - primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
 - cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| RPGR | ENST00000645032.1  | c.2606_2620delAAGAAGGGGAGGAAG | p.Glu869_Glu873del | disruptive_inframe_deletion | Exon 15 of 15 | NM_001034853.2 | ENSP00000495537.1 | |||
| ENSG00000250349 | ENST00000465127.1  | c.172-379741_172-379727delTTCCTCCCCTTCTTC | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00352  AC: 78AN: 22175Hom.:  0  Cov.: 5 show subpopulations 
GnomAD2 exomes  AF:  0.000575  AC: 24AN: 41741 AF XY:  0.000164   show subpopulations 
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF:  0.00644  AC: 4453AN: 690972Hom.:  53   AF XY:  0.00743  AC XY: 1399AN XY: 188180 show subpopulations 
Age Distribution
GnomAD4 genome  Data not reliable, filtered out with message: AS_VQSR AF:  0.00352  AC: 78AN: 22180Hom.:  0  Cov.: 5 AF XY:  0.000929  AC XY: 1AN XY: 1076 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:3 
RPGR: BS1, BS2 -
- -
- -
X-linked cone-rod dystrophy 1    Uncertain:1 
Class 3 ACMG Guidelines, 2015 -
not specified    Benign:1 
- -
Primary ciliary dyskinesia    Benign:1 
- -
RPGR-related retinopathy    Benign:1 
NM_001034853.2(RPGR):c.2606_2620del (p.Glu869_Glu873del) is a short in-frame deletion of 15 nucleotides that encode amino acids 869–873 within a low-complexity region (PMID: 27162334) that extends approximately from amino acids 787–1043 in RPGR (BP3). This variant is present in gnomAD v4.1.0 at a frequency of 0.007397 among hemizygous individuals, with 1,400 variant alleles / 189,256 total alleles, which is higher than the ClinGen X-linked IRD VCEP BA1 threshold of >0.00005 (BA1). In summary, this variant is classified as benign for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; BA1 and BP3. (date of approval 05/16/2025). -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at